Open an account

Nexentis Technologies

NXTS · NASDAQ

$0.6153−$0.0251 (−3.92%)TodayMarket closed ·
Prev close $0.6404

About NXTS

Nexentis Technologies, Inc. is a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech. The company employs 7 full-time employees The company went IPO on 2010-05-26. Through its subsidiary MitoCareX Bio Ltd. The firm uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. The company enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.

Employees
7
Headquarters
New York City, New York
Listed
May 26, 2010
Sector
Materials
Industry
Chemicals
Website
n2off.com

NXTS key statistics

Market cap
894.24K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.02M
Volume
113.95K
Open price
$0.626
High today
$0.6299
Low today
$0.5679
52 Week high
$30.28
52 Week low
$0.5994

Nexentis Technologies (NXTS) at a glance

Nexentis Technologies (NXTS) last traded at $0.6153, with a market cap of 894.24K and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.5679 and $0.6299. The current price is 8.3% above the day's low and 2.3% below its high.

Volume so far is 113.95K shares, below the average of 1.02M shares a day.

Over the past year Nexentis Technologies has ranged from $0.5994 to $30.28, and now sits 0% of the way up that range.

Nexentis Technologies met or beat analyst EPS estimates in 0 of the last 2 quarters. In Q2 FY25 it reported -$0.18 per share against an estimate of $0.00.

NXTS earnings

Earnings per share, reported against the analyst estimate

Didn’t beat the estimate in any of the last 2 quarters.

  1. Q1 FY25: reported -$0.39 per share against an estimate of $0.00
  2. Q2 FY25: reported -$0.18 per share against an estimate of $0.00

NXTS news

  • Avi Kapoor

    Crude Oil Down Over 1%; US Manufacturing PMI Surges In June

  • Avi Kapoor

    Dow Falls Over 300 Points; Korn Ferry Earnings Top Views

  • Tanya Rawat

    Nexentis Technologies Soars 156% Before Falling 46% After Hours — Here’s Why NXTS Stock Is Trending

  • Avi Kapoor

    Crude Oil Falls Over 2%; Getty Images Shares Spike Higher

  • Avi Kapoor

    Dow Jumps 200 Points; Outdoor Holding Shares Fall After Q4 Results

  • Press releaseGlobe Newswire

    Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.